|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
100,490,000 |
Market
Cap: |
6.33(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.24 - $94.5 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. Co.'s primary clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRss). Co. is also developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRss for X-linked adrenoleukodystrophy, a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
348,181 |
852,260 |
852,260 |
1,615,026 |
Total Sell Value |
$27,122,482 |
$40,299,016 |
$40,299,016 |
$54,614,939 |
Total People Sold |
2 |
4 |
4 |
6 |
Total Sell Transactions |
2 |
9 |
9 |
23 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mancini Marianna |
Chief Operating Officer |
|
2024-01-04 |
4 |
D |
$18.58 |
$263,817 |
D/D |
(14,199) |
333,799 |
|
- |
|
Lian Brian |
President & CEO |
|
2024-01-04 |
4 |
D |
$18.58 |
$734,876 |
D/D |
(39,552) |
2,264,882 |
|
- |
|
Zante Greg |
Chief Financial Officer |
|
2024-01-03 |
4 |
D |
$17.40 |
$854,723 |
D/D |
(49,122) |
209,602 |
|
- |
|
Zante Greg |
Chief Financial Officer |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
98,334 |
240,491 |
|
- |
|
Mancini Marianna |
Chief Operating Officer |
|
2024-01-03 |
4 |
D |
$17.40 |
$856,254 |
D/D |
(49,210) |
347,998 |
|
- |
|
Mancini Marianna |
Chief Operating Officer |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
98,334 |
380,675 |
|
- |
|
Lian Brian |
President & CEO |
|
2024-01-03 |
4 |
D |
$17.40 |
$3,734,736 |
D/D |
(214,640) |
2,304,434 |
|
- |
|
Lian Brian |
President & CEO |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
310,000 |
2,410,549 |
|
- |
|
Rowland Charles A Jr |
Director |
|
2023-05-16 |
4 |
AS |
$25.00 |
$1,000,000 |
D/D |
(40,000) |
30,000 |
|
-53% |
|
Rowland Charles A Jr |
Director |
|
2023-05-16 |
4 |
OE |
$1.08 |
$43,200 |
D/D |
40,000 |
70,000 |
|
- |
|
Macartney Lawson |
Director |
|
2023-05-16 |
4 |
AS |
$24.00 |
$384,000 |
D/D |
(16,000) |
47,965 |
|
-53% |
|
Macartney Lawson |
Director |
|
2023-05-16 |
4 |
OE |
$1.19 |
$19,040 |
D/D |
16,000 |
63,965 |
|
- |
|
Lian Brian |
President & CEO |
|
2023-05-01 |
4 |
AS |
$22.45 |
$1,010,250 |
D/D |
(45,000) |
2,197,963 |
|
-28% |
|
Macartney Lawson |
Director |
|
2023-04-24 |
4 |
AS |
$22.00 |
$352,061 |
D/D |
(16,000) |
47,965 |
|
-35% |
|
Macartney Lawson |
Director |
|
2023-04-24 |
4 |
OE |
$3.33 |
$53,280 |
D/D |
16,000 |
63,965 |
|
- |
|
Lian Brian |
President & CEO |
|
2023-04-19 |
4 |
AS |
$21.45 |
$750,750 |
D/D |
(35,000) |
2,242,963 |
|
-34% |
|
Zante Greg |
Chief Financial Officer |
|
2023-04-17 |
4 |
AS |
$20.00 |
$150,000 |
D/D |
(7,500) |
149,279 |
|
-31% |
|
Zante Greg |
Chief Financial Officer |
|
2023-04-17 |
4 |
OE |
$13.07 |
$98,025 |
D/D |
7,500 |
156,779 |
|
- |
|
Lian Brian |
President & CEO |
|
2023-04-17 |
4 |
AS |
$20.45 |
$3,169,766 |
D/D |
(155,000) |
2,277,963 |
|
-31% |
|
Lian Brian |
President & CEO |
|
2023-04-17 |
4 |
OE |
$2.15 |
$268,750 |
D/D |
125,000 |
2,432,963 |
|
- |
|
Macartney Lawson |
Director |
|
2023-04-17 |
4 |
AS |
$20.00 |
$415,720 |
D/D |
(20,786) |
47,965 |
|
-31% |
|
Macartney Lawson |
Director |
|
2023-04-17 |
4 |
OE |
$8.00 |
$166,288 |
D/D |
20,786 |
68,751 |
|
- |
|
Mancini Marianna |
Chief Operating Officer |
|
2023-04-17 |
4 |
AS |
$20.00 |
$250,000 |
D/D |
(12,500) |
287,763 |
|
-31% |
|
Mancini Marianna |
Chief Operating Officer |
|
2023-04-17 |
4 |
OE |
$13.07 |
$163,375 |
D/D |
12,500 |
300,263 |
|
- |
|
Lian Brian |
President & CEO |
|
2023-04-13 |
4 |
AS |
$18.45 |
$1,463,749 |
D/D |
(79,336) |
2,307,963 |
|
-23% |
|
162 Records found
|
|
Page 2 of 7 |
|
|